biotronik News

Company Announces FDA-Approved, Clinically-Supported Labeling Instructions

Physicians now can make more-informed decisions in cardiac device replacement

BIOTRONIK Inc. announced today the U.S. launch of its Lumax 540 series, technologically advanced devices using industry-leading features to save and enhance patients’ lives.

BIOTRONIK Inc. introduced today the Lumax 540 with all-new pacing technology features, reaffirming the company’s technological leadership in heart monitoring devices.

Study Investigates Use of Remote Monitoring to Reduce Risk of Strokes in Patients with Atrial Fibrillation